The results revealed that ZBPYR exhibited promising antidiabetic effects by moderating the increased RBG levels during the 3rd to 6th weeks of treatment and significantly improving the impaired glucose tolerance and insulin sensitivity. This evidence concerns the gene INS and Impaired glucose tolerance.